May 31, 2024 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q4 FY '24 earnings conference call of Marksans Pharma Limited, hosted by Elara Securities Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Dr. Bino Pathiparampil from Elara Securities Limited. Thank you and over to you.
Bino Pathiparampil - Elara Securities Limited - Analyst
Thank you, Yashashri. Good evening to all of you on the call. On behalf of Elara Securities, I, Dr. Bino Pathiparampil, welcome you all to the management call of Marksans Pharma to discuss the Q4 and full year FY '24 earnings release and the business outlook. We have with us Mark Saldanha, Chairman and MD; and Jitendra Sharma, CFO. I now hand over the call to Mark and Jitendra. Over to you.
Mark Saldanha - Marksans Pharma Ltd - Executive Chairman of the Board, Managing Director
Thank you, Bino. Welcome, everyone, and thank you for joining us in our Q4 FY24 earnings conference call. We appreciate your continued interest and
Q4 2024 Marksans Pharma Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot